Read our Latest Press Release

As with most compounds, over consumption of CBD may have negative health effects. However, taking CBD in moderation is not thought to cause harmful side effects. That being said, research is still ongoing on the potential health benefits and complications of using CBD. Some of the potential health risks that may be associated with CBD consumption […]

One of the reasons why CBD has become such an important commodity is its many potential uses. Although research is still being conducted to determine the full health benefits of CBD, retailers may sell CBD products in a variety of forms. Here are some of the most popular types of CBD products on the market […]

How long CBD statins stay in the body depends on how much is ingested and how it is taken. CBD can stay in the body anywhere from a few hours to a month. Taking CBD orally tends to extend the time it stays in the body. This means that foods and oils taken orally will […]

Cannabidiol (CBD) has tremendous therapeutic potential, but its development as an effective drug for the pharmaceutical industry is hampered by intrinsic properties such as low bioavailability, low aqueous solubility, and variable pharmacokinetic profiles. Potential avenues to overcome these issues for CBD include self-emulsifying drug delivery systems, improved crystalline formulations, and other solid-state delivery formulations, most […]

A prescription form of CBD is approved for treating seizure disorders (such as epilepsy). While CBD is also used for conditions like anxiety, pain, dystonia (a muscle disorder), Parkinson’s disease, Crohn’s disease, and more, there is insufficient scientific evidence to support its effectiveness for these uses. In 2018, laws were passed that legalized the sale […]

“Wishing all our valued partners, clients, and colleagues a Merry Christmas and a joyful holiday season from the VPLUS team! May the new year bring success, growth, and continued collaboration.”

The lung’s delicate surfactant layer is of critical importance to the organ’s overall physiology and innate immune function. Both alveolar type II cells and alveolar macrophages are the principal subsets that maintain and catabolize surfactant at the liquid-air interface. Our study reveals that ENDS exposure disrupts both the lipid and protein components of pulmonary surfactant, […]

Neurodegenerative diseases leading to Parkinson’s disease (PD) and Alzheimer’s disease (AD) have become a major global health burden. Current treatments are mainly aimed at controlling symptoms, and there are no effective treatments in clinical practice to prevent neurodegeneration or induce neuronal repair. Therefore, the need for new research on these two diseases is urgent. The […]